Description

Semax is a synthetic analog of the adrenocorticotropic hormone (ACTH) fragment 4–10, modified to enhance stability and activity within the central nervous system without stimulating adrenal hormone production. It has been extensively studied in research settings for its nootropic (cognitive-enhancing) and neuroprotective effects.

One of its primary mechanisms involves upregulation of brain-derived neurotrophic factor (BDNF), a protein critical for neuronal growth, synaptic plasticity, learning, and memory formation. Semax has also been shown in research models to influence dopaminergic and serotonergic systems, contributing to improved attention, mental clarity, and stress resilience.

In addition to cognitive support, Semax has been investigated for its potential role in neuroprotection, including support during oxidative stress and ischemic conditions. Rather than acting as a stimulant, Semax appears to work through regulatory effects at the gene-expression and neurotrophic level.

Semax is most commonly studied via intranasal administration, though subcutaneous use is also explored

in some research contexts. It is not classified as a hormone or stimulant and is typically researched in short cycles.